Effects of pentoxifylline in adriamycin-induced renal disease in rats.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0931-041X (Print) Linking ISSN: 0931041X NLM ISO Abbreviation: Pediatr Nephrol Subsets: MEDLINE
    • Publication Information:
      Publication: Berlin : Springer International
      Original Publication: Berlin : Springer International, c1987-
    • Subject Terms:
      Doxorubicin*/administration & dosage; Apoptosis/*drug effects ; Kidney Diseases/*metabolism ; Pentoxifylline/*pharmacology ; Proteinuria/*chemically induced ; Tumor Necrosis Factor-alpha/*analysis ; Tumor Necrosis Factor-alpha/*antagonists & inhibitors; Animals ; Kidney Diseases/chemically induced ; Rats ; Rats, Wistar
    • Abstract:
      Tumor necrosis factor-alpha (TNF-alpha) is a mediator of inflammation in human and animal renal disease. Pentoxiphylline (PTX) is an inhibitor of TNF-alpha. In this study we examined the effects of PTX on TNF-alpha, proteinuria, nitrite production, and apoptosis in an experimental model of Adriamycin (ADR) nephropathy in rats. Rats were divided into four groups: untreated Wistar rats (controls), PTX treatment alone, ADR treatment alone to induce nephropathy, and ADR treatment followed by PTX. ADR treatment followed by PTX treatment prevented the increase in serum TNF-alpha levels and proteinuria in rats with ADR-nephropathy ( P<0.05). Urine nitrite levels were significantly increased in the ADR-induced nephropathy group and the increase was prevented in the ADR-induced nephropathy group when they also received PTX. The urine nitrite levels were not different between the PTX-treated group and the untreated control rats. PTX prevented the rise of serum TNF-alpha in ADR nephropathy rats and a decrease in proteinuria, urine nitrite, and apoptosis in the renal tissue. These findings suggest a beneficial anti-inflammatory effect of PTX.
    • References:
      Lancet. 2001 May 26;357(9269):1672-3. (PMID: 11425374)
      Lab Invest. 1994 Apr;70(4):449-59. (PMID: 8176885)
      J Am Soc Nephrol. 2002 Dec;13(12):2916-29. (PMID: 12444210)
      Am J Physiol Cell Physiol. 2001 Aug;281(2):C563-70. (PMID: 11443055)
      Biol Neonate. 1995;67(1):72-6. (PMID: 7538329)
      Kidney Int. 1999 Sep;56(3):932-43. (PMID: 10469361)
      Eur J Pharmacol. 2003 May 23;469(1-3):21-8. (PMID: 12782181)
      J Rheumatol. 2003 Nov;30(11):2382-4. (PMID: 14677181)
      Circ Res. 2003 Feb 21;92 (3):293-9. (PMID: 12595341)
      Nephrol Dial Transplant. 2001 Jan;16(1):32-8. (PMID: 11208990)
      Miner Electrolyte Metab. 1995;21(4-5):336-41. (PMID: 7565482)
      J Cardiovasc Pharmacol. 1995;25 Suppl 2:S71-4. (PMID: 8699866)
      Nephron. 1994;66(3):291-4. (PMID: 8190181)
      Nephron. 2000 Oct;86(2):99-104. (PMID: 11014976)
      Nephrol Dial Transplant. 2004 May;19(5):1106-15. (PMID: 14993492)
      Ren Fail. 2003 Nov;25(6):909-22. (PMID: 14669850)
      Immunobiology. 1993 Apr;187(3-5):447-63. (PMID: 8330908)
    • Accession Number:
      0 (Tumor Necrosis Factor-alpha)
      80168379AG (Doxorubicin)
      SD6QCT3TSU (Pentoxifylline)
    • Publication Date:
      Date Created: 20040619 Date Completed: 20050426 Latest Revision: 20220408
    • Publication Date:
      20240104
    • Accession Number:
      10.1007/s00467-004-1538-5
    • Accession Number:
      15206020